Characteristics and serotype distribution of childhood cases of invasive pneumococcal disease following pneumococcal conjugate vaccination in England and Wales, 2006–2014
Clinical Infectious Diseases
Oligbu G, et al.
Authors here aim at assessing the risk, clinical characteristics, or outcomes of 13–valent pneumococcal conjugate vaccine (PCV13) compared to 7–valent pneumococcal conjugate vaccine (PCV7) failure. Observations reveal that PCV failure is rare and, compared to PCV7 serotypes, the additional PCV13 serotypes are more likely to cause bacteremic lower respiratory tract infection (LRTI) and empyema in healthy vaccinated children.
Your browser is currently blocking ads. We depend on ad sponsorships in order to keep this site free to the healthcare provider community. Help us keep this site free by turning off your ad blocker.
Turn Off Ad Blocker
We have detected that you are currently blocking ads. We kindly ask that you enable ads when visiting our site. We depend on ad sponsorships in order to keep this site free to the healthcare provider community.